BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2750210)

  • 1. Propranolol metabolism by Cunninghamella bainieri.
    Foster BC; Buttar HS; Qureshi SA; McGilveray IJ
    Xenobiotica; 1989 May; 19(5):539-46. PubMed ID: 2750210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sparteine and quinidine on the metabolism of methoxyphenamine by Cunninghamella bainieri.
    Foster BC; Wilson DL; McGilveray IJ
    Xenobiotica; 1989 Apr; 19(4):445-52. PubMed ID: 2750204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assessment of cytotoxicity and biotransformation of propranolol in Cunninghamella echinulata.
    Foster BC; Litster DL; Wilson DL; Ormsby E; Dawson BA
    Xenobiotica; 1992 Nov; 22(11):1221-8. PubMed ID: 1492414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of aryl alkylamines by Cunninghamella bainieri.
    Foster BC; Coutts RT; Pasutto FM
    Xenobiotica; 1989 May; 19(5):531-8. PubMed ID: 2750209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of tri-substituted methoxyamphetamines by Cunninghamella echinulata.
    Foster BC; McLeish J; Wilson DL; Whitehouse LW; Zamecnik J; Lodge BA
    Xenobiotica; 1992 Dec; 22(12):1383-94. PubMed ID: 1494884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
    Marathe PH; Shen DD; Nelson WL
    Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial production of phase I and phase II metabolites of propranolol.
    Marvalin C; Azerad R
    Xenobiotica; 2011 Mar; 41(3):175-86. PubMed ID: 21110747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial models of mammalian metabolism. N-dealkylation of furosemide to yield the mammalian metabolite CSA using Cunninghamella elegans.
    Hezari M; Davis PJ
    Drug Metab Dispos; 1992; 20(6):882-8. PubMed ID: 1362941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial models of mammalian metabolism: conversion of warfarin to 4'-hydroxywarfarin using Cunninghamella bainieri.
    Rizzo JD; Davis PJ
    J Pharm Sci; 1989 Mar; 78(3):183-9. PubMed ID: 2724074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathways of propranolol metabolism in dog and rat liver 10,000g supernatant fractions.
    Vu VT; Abramson FP
    Drug Metab Dispos; 1980; 8(5):300-4. PubMed ID: 6107225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of propranolol in the human maternal-placental-foetal unit.
    Smith MT; Livingstone I; Eadie MJ; Hooper WD; Triggs EJ
    Eur J Clin Pharmacol; 1983; 24(6):727-32. PubMed ID: 6884410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dose and uremia on plasma and urine profiles of propranolol metabolites.
    Schneck DW; Pritchard JF; Gibson TP; Vary JE; Hayes AH
    Clin Pharmacol Ther; 1980 Jun; 27(6):744-55. PubMed ID: 7379441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of 2-, 3-, and 4-methoxy-amphetamines by Cunninghamella echinulata.
    Foster BC; Litster DL; Lodge BA
    Xenobiotica; 1991 Oct; 21(10):1337-46. PubMed ID: 1796610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial biotransformation of retinoic acid by Cunninghamella echinulata and Cunninghamella blakesleeana.
    Hartman DA; Basil JB; Robertson LW; Curley RW
    Pharm Res; 1990 Mar; 7(3):270-3. PubMed ID: 2339101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased absorption as a possible cause for the lower bioavailability of a sustained-release propranolol.
    Takahashi H; Ogata H; Warabioka R; Kashiwada K; Ohira M; Someya K
    J Pharm Sci; 1990 Mar; 79(3):212-5. PubMed ID: 2338628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial models of mammalian metabolism: stereoselective metabolism of warfarin in the fungus Cunninghamella elegans.
    Wong YW; Davis PJ
    Pharm Res; 1989 Nov; 6(11):982-7. PubMed ID: 2594692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biotransformation of tranylcypromine by Cunninghamella echinulata.
    Foster BC; Litster DL; Zamecnik J; Coutts RT
    Can J Microbiol; 1991 Oct; 37(10):791-5. PubMed ID: 1777857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of propranolol during percutaneous absorption in human skin.
    Ademola JI; Chow CA; Wester RC; Maibach HI
    J Pharm Sci; 1993 Aug; 82(8):767-70. PubMed ID: 8377110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorometric TLC determination of free and conjugated propranolol, naphthoxylactic acid, and p-hydroxypropranolol in human plasma and urine.
    Garceau Y; Davis I; Hasegawa J
    J Pharm Sci; 1978 Jun; 67(6):826-31. PubMed ID: 660467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselective analysis of propranolol and 4-hydroxypropranolol by CE with application to biotransformation studies employing endophytic fungi.
    Borges KB; Pupo MT; Bonato PS
    Electrophoresis; 2009 Nov; 30(22):3910-7. PubMed ID: 19876961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.